Skip to content
DraconiticResearch
Search Sources API
194,067 studies31 sourcesUpdated just now
Peer-reviewedPublisher termsRSC Medicinal Chemistry

Novel triazolo[1,5]benzodiazepines as potent dual AChE/BChE inhibitors for Alzheimer's disease: synthesis, characterization, in vitro and in silico studies

  • Marouane Ait Lahcen1
  • Halil Şenol2
  • Saad Zekri1
  • Nastaran Sadeghian3
  • Samir Hmaimou1
  • Laura Chelazzi4
  • Samuele Ciattini4
  • Elena Zaballos-García5
  • Parham Taslimi3
  • Ismail Hdoufane1
  • Driss Cherqaoui1
  • Abdesselam Baouid1
1 more authors
  • Mohamed Adardour1
5 affiliations
  1. 1Faculty of Sciences Semlalia, Molecular Chemistry Laboratory, Department of Chemistry, UCA, Cadi Ayyad University PB 2390 Marrakech 40001 Morocco
  2. 2Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Bezmialem Vakif University 34093 Fatih İstanbul Türkiye
  3. 3Department of Biotechnology, Faculty of Science, Bartin University 74110 Bartin Türkiye
  4. 4Centro di Cristallografia, University of Florence Via della Lastruccia 3, I-50019 Sesto Fiorentino Florence Italy
  5. 5Departamento de Quimica Organica, Facultad de Farmacia, Universidad de Valencia Ave. Vte. Andres Estelles s/n46100 Valencia Spain
Read full textDOICite

Related

  1. Design, synthesis, and biological evaluation of naphthalimide derivatives as dual monoamine oxidase-B and amyloid-β aggregation inhibitors for Alzheimer's disease.
    Rukshar Praveen, Alessandro Gadaleta, Gabriella La Spada +6
    RSC advancesPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  2. Design, synthesis, and antifungal activity of (phenylethynyl) phenoxymethyl-1,3-dioxolane triazoles as novel CYP51 inhibitors
    Zixuan Gao, Cancan Cui, Mingshuo Chen +7
    RSC Medicinal ChemistryPeer-reviewedPublisher termsFull textInfectious diseasePMC
  3. Comparative risk of injury among users of benzodiazepines and related drugs concomitantly with clarithromycin versus azithromycin: a retrospective cohort study of US Medicaid enrollees.
    Kacie Bogar, Cheng Chen, Colleen Brensinger +10
    BMJ openPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMCCrossref
  4. Real-world effectiveness of monoclonal antibody lecanemab versus acetylcholinesterase inhibitors in Alzheimer’s disease: a target trial emulation
    Chuo-Yu Lee, Chih-Wei Hsu, Ping-Tao Tseng +9
    Alzheimer's Research & TherapyPeer-reviewedCC BY-NC-ND 4.0Full textPhysiologyPMC
  5. Rhodanine and 2,4-dioxothiazolidine-based amides: synthesis and evaluation as dual-action cholinesterase inhibitors and antioxidants.
    Enikő Šikorová, Adéla Kyslíková, Markéta Švarcová +3
    RSC medicinal chemistryPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC

Cite

BibTeXRIS
BibTeX
@article{lahcen2026novel,
  title = {{Novel triazolo[1,5]benzodiazepines as potent dual AChE/BChE inhibitors for Alzheimer's disease: synthesis, characterization, in vitro and in silico studies}},
  author = {Marouane Ait Lahcen and Halil Şenol and Saad Zekri and Nastaran Sadeghian and Samir Hmaimou and Laura Chelazzi and Samuele Ciattini and Elena Zaballos-García and Parham Taslimi and Ismail Hdoufane and Driss Cherqaoui and Abdesselam Baouid and Mohamed Adardour},
  journal = {RSC Medicinal Chemistry},
  year = {2026},
  month = nov,
  doi = {10.1039/d6md00416d},
  url = {https://doi.org/10.1039/d6md00416d},
}
RIS
TY  - JOUR
TI  - Novel triazolo[1,5]benzodiazepines as potent dual AChE/BChE inhibitors for Alzheimer's disease: synthesis, characterization, in vitro and in silico studies
AU  - Marouane Ait Lahcen
AU  - Halil Şenol
AU  - Saad Zekri
AU  - Nastaran Sadeghian
AU  - Samir Hmaimou
AU  - Laura Chelazzi
AU  - Samuele Ciattini
AU  - Elena Zaballos-García
AU  - Parham Taslimi
AU  - Ismail Hdoufane
AU  - Driss Cherqaoui
AU  - Abdesselam Baouid
AU  - Mohamed Adardour
PY  - 2026
DA  - 2026/11/02
JO  - RSC Medicinal Chemistry
DO  - 10.1039/d6md00416d
UR  - https://doi.org/10.1039/d6md00416d
SN  - 2632-8682
ER  -